“I think this is the ground floor of a market that could be worth more than $29 billion by the end of the decade,” declares the author of today’s article of the “New Biotech” sector he discusses: psychedelics. For more on the potential profit opportunities associated with the “Shroom Boom” – especially in light of recent news regarding an important, successful FDA…
“The kinds of biotechs best for investors who aren’t huge risk-takers are those that generate solid revenue growth, are profitable (or soon will be), and have promising pipelines,” advises the author of today’s article, who proceeds to highlight three stocks that appear to match this profile to consider buying this month. For more, CLICK HERE.
While the Volatility Index (or VIX), a popular measure of implied market volatility, is not as high as it was recently, it is still well above normal levels – and the author of today’s article highlights a trade to consider to profit from this highly volatile trading environment in which “options’ premium is all plumped up and ready for feasting…
A real estate investment trust that is required to pay out the bulk of its profits as dividends (and whose management anticipates 4% annual dividend growth over the next 3 years), a well-run Canadian pipeline giant that is likely to increase its payout significantly in the coming quarters, and a renewable energy focused yieldco whose management expects 12% to 15%…
One of the macro-level changes in the investment landscape has been the large-scale shift by investors into indexes and ETFs (and away from stocks and mutual funds) – a shift that the author of today’s article sees as being based on misplaced beliefs, and one that he warns will cost those investors – especially younger investors – in the long…
For investors in their 50s looking to both grow their retirement nest eggs and build a steady stream of passive income, today’s article highlights one stock which, “with its powerful wealth-building combination of increasing dividend payouts and share-price appreciation”, may be one of the best picks for achieving both of these goals. To find out what this stock is –…
The post-election “Trump rally” has been very good to investors. But, as today’s article notes, “retirees…have a vested interest in making sure their newly plumped-up nest eggs remain intact.” So, should retirees head for the exits in anticipation of a pullback, or would doing so likely cause them to miss out on further gains next year? The author looks at…